Menu
GeneBe

6-151536319-A-G

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The NM_025059.4(CCDC170):c.59A>G(p.Glu20Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,274 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000029 ( 2 hom. )

Consequence

CCDC170
NM_025059.4 missense, splice_region

Scores

19
Splicing: ADA: 0.0003012
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.887
Variant links:
Genes affected
CCDC170 (HGNC:21177): (coiled-coil domain containing 170) The function of this gene and its encoded protein is not known. Several genome-wide association studies have implicated the region around this gene to be involved in breast cancer and bone mineral density, but no link to this specific gene has been found. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015950859).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CCDC170NM_025059.4 linkuse as main transcriptc.59A>G p.Glu20Gly missense_variant, splice_region_variant 2/11 ENST00000239374.8
CCDC170XM_011536147.3 linkuse as main transcriptc.77A>G p.Glu26Gly missense_variant, splice_region_variant 2/11
CCDC170XM_011536148.3 linkuse as main transcriptc.77A>G p.Glu26Gly missense_variant, splice_region_variant 2/10
CCDC170XM_047419372.1 linkuse as main transcriptc.59A>G p.Glu20Gly missense_variant, splice_region_variant 2/10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CCDC170ENST00000239374.8 linkuse as main transcriptc.59A>G p.Glu20Gly missense_variant, splice_region_variant 2/111 NM_025059.4 P1
CCDC170ENST00000544131.1 linkuse as main transcriptn.49A>G non_coding_transcript_exon_variant 1/34

Frequencies

GnomAD3 genomes
AF:
0.0000525
AC:
8
AN:
152248
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000481
AC:
12
AN:
249264
Hom.:
0
AF XY:
0.0000592
AC XY:
8
AN XY:
135208
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000392
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000287
AC:
42
AN:
1460908
Hom.:
2
Cov.:
31
AF XY:
0.0000385
AC XY:
28
AN XY:
726562
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000441
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152366
Hom.:
0
Cov.:
33
AF XY:
0.0000940
AC XY:
7
AN XY:
74502
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00166
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
ExAC
AF:
0.0000828
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 20, 2021The c.59A>G (p.E20G) alteration is located in exon 2 (coding exon 2) of the CCDC170 gene. This alteration results from a A to G substitution at nucleotide position 59, causing the glutamic acid (E) at amino acid position 20 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.062
BayesDel_addAF
Benign
-0.58
T
BayesDel_noAF
Benign
-0.74
Cadd
Benign
18
Dann
Benign
0.97
DEOGEN2
Benign
0.0027
T
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.50
FATHMM_MKL
Benign
0.74
D
LIST_S2
Benign
0.38
T
M_CAP
Benign
0.014
T
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.5
L
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-2.1
N
REVEL
Benign
0.035
Sift
Benign
0.27
T
Sift4G
Benign
0.091
T
Polyphen
0.0060
B
Vest4
0.081
MutPred
0.099
Loss of stability (P = 0.0644);
MVP
0.15
MPC
0.14
ClinPred
0.059
T
GERP RS
3.5
Varity_R
0.070
gMVP
0.21

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00030
dbscSNV1_RF
Benign
0.064
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs564119648; hg19: chr6-151857454; API